News
Zai Lab Limited today announced that updated data from an ongoing, global Phase 1a/1b clinical trial (NCT06179069) evaluating ZL-1310, the Company's potential first-in-class and best-in-class, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback